See All Slides - tctmd.com

Slides

Presentation TCT 2013

Deep-dive Insights from the 5-year SYNTAX Left Main Results, and Relevance to 2013 Technology

Presenter: Marie-Claude Morice

October 28, 2013

Presentation TCT 2013

Changing Vessel Compliance to Treat Hypertension (Rox Medical)

Presenter: David Deaton

October 28, 2013

Presentation TCT 2013

The Subintimal Antegrade Hypothesis Emerges: Rationale and Lessons from the Hybrid Registry

Presenter: Craig Thompson

October 28, 2013

Presentation TCT 2013

Who Should Be Operated on for Functional MR? Guidelines and Practice (Surgical Perspectives)

Presenter: Michael Mack

October 28, 2013

Presentation TCT 2013

SYNTAX COST-EFFECTIVENESS: Final Five-Year Results from a Prospective, Randomized Trial of Paclitaxel-Eluting Stents vs. CABG in Patients with Triple Vessel and Left Main Corona...

Presenter: David Cohen

October 28, 2013

Presentation TCT 2013

Percutaneous Management of Vascular Complications After TAVR

Presenter: Peter Wenaweser

October 28, 2013

Presentation TCT 2013

Case #8: Why I Attempted an RCA CTO Five Times (And What I Did Different to Succeed)

Presenter: William Lombardi

October 28, 2013

Presentation TCT 2013

SAVR

Presenter: Craig Smith

October 28, 2013

Presentation TCT 2013

Should the Presence of Diabetes Move Treatment Toward CABG Rather Than PCI? Historical Observations and Syntax Score II

Presenter: Patrick Serruys

October 28, 2013

Presentation TCT 2013

PARTNER: A Propensity-Matched Comparison of Clinical Outcomes After Transapical vs. Transfemoral TAVR

Presenter: Eugene Blackstone

October 28, 2013

Advertisement

Slides

Deep-dive Insights from the 5-year SYNTAX Left Main Results, and Relevance to 2013 Technology

Changing Vessel Compliance to Treat Hypertension (Rox Medical)

The Subintimal Antegrade Hypothesis Emerges: Rationale and Lessons from the Hybrid Registry

Who Should Be Operated on for Functional MR? Guidelines and Practice (Surgical Perspectives)

SYNTAX COST-EFFECTIVENESS: Final Five-Year Results from a Prospective, Randomized Trial of Paclitaxel-Eluting Stents vs. CABG in Patients with Triple Vessel and Left Main Corona...

Percutaneous Management of Vascular Complications After TAVR

Case #8: Why I Attempted an RCA CTO Five Times (And What I Did Different to Succeed)

SAVR

Should the Presence of Diabetes Move Treatment Toward CABG Rather Than PCI? Historical Observations and Syntax Score II

PARTNER: A Propensity-Matched Comparison of Clinical Outcomes After Transapical vs. Transfemoral TAVR

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content